Prestidge CA - Search Results

1

Lipophilic Prodrugs of SN38: Synthesis and in Vitro Characterization toward Oral Chemotherapy.

Bala V, Rao S, Li P, Wang S, Prestidge CA. Bala V, et al. Among authors: prestidge ca. Mol Pharm. 2016 Jan 4;13(1):287-94. doi: 10.1021/acs.molpharmaceut.5b00785. Epub 2015 Dec 16. Mol Pharm. 2016. PMID: 26623947

2

Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.

Simovic S, Heard P, Hui H, Song Y, Peddie F, Davey AK, Lewis A, Rades T, Prestidge CA. Simovic S, et al. Among authors: prestidge ca. Mol Pharm. 2009 May-Jun;6(3):861-72. doi: 10.1021/mp900063t. Mol Pharm. 2009. PMID: 19358600

3

Chemical stability and phase distribution of all-trans-retinol in nanoparticle-coated emulsions.

Eskandar NG, Simovic S, Prestidge CA. Eskandar NG, et al. Among authors: prestidge ca. Int J Pharm. 2009 Jul 6;376(1-2):186-94. doi: 10.1016/j.ijpharm.2009.04.036. Epub 2009 May 5. Int J Pharm. 2009. PMID: 19422895

4

Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs.

Wang F, Hui H, Barnes TJ, Barnett C, Prestidge CA. Wang F, et al. Among authors: prestidge ca. Mol Pharm. 2010 Feb 1;7(1):227-36. doi: 10.1021/mp900221e. Mol Pharm. 2010. PMID: 19874003

5

Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems.

Tan A, Simovic S, Davey AK, Rades T, Boyd BJ, Prestidge CA. Tan A, et al. Among authors: prestidge ca. Mol Pharm. 2010 Apr 5;7(2):522-32. doi: 10.1021/mp9002442. Mol Pharm. 2010. PMID: 20063867

6

Surface analysis for compositional, chemical and structural imaging in pharmaceutics with mass spectrometry: a ToF-SIMS perspective.

Barnes TJ, Kempson IM, Prestidge CA. Barnes TJ, et al. Among authors: prestidge ca. Int J Pharm. 2011 Sep 30;417(1-2):61-9. doi: 10.1016/j.ijpharm.2011.01.043. Epub 2011 Jan 26. Int J Pharm. 2011. PMID: 21277966 Review.

7

Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro performance.

Lim LH, Tan A, Simovic S, Prestidge CA. Lim LH, et al. Among authors: prestidge ca. Int J Pharm. 2011 May 16;409(1-2):297-306. doi: 10.1016/j.ijpharm.2011.02.038. Epub 2011 Mar 1. Int J Pharm. 2011. PMID: 21371543

8

Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Tan A, Rao S, Prestidge CA. Tan A, et al. Among authors: prestidge ca. Pharm Res. 2013 Dec;30(12):2993-3017. doi: 10.1007/s11095-013-1107-3. Epub 2013 Jun 18. Pharm Res. 2013. PMID: 23775443 Review.

9

Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.

Bala V, Rao S, Boyd BJ, Prestidge CA. Bala V, et al. Among authors: prestidge ca. J Control Release. 2013 Nov 28;172(1):48-61. doi: 10.1016/j.jconrel.2013.07.022. Epub 2013 Aug 6. J Control Release. 2013. PMID: 23928356 Review.

10

Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms.

Jardeleza C, Rao S, Thierry B, Gajjar P, Vreugde S, Prestidge CA, Wormald PJ. Jardeleza C, et al. Among authors: prestidge ca. PLoS One. 2014 Mar 21;9(3):e92117. doi: 10.1371/journal.pone.0092117. eCollection 2014. PLoS One. 2014. PMID: 24658315 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters